Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical Inc.
1:16-cv-00431
Overview
Parties
Defendant
Novartis AG Operating Company
Represented By
3 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Novartis Pharmaceuticals Corporation Operating Company
Represented By
7 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Plaintiff
Breckenridge Pharmaceutical Inc. Operating Company
Represented By
6 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Delaware Court of Chancery
Delaware Court of Chancery, 500 North King Street
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Hikma Pharmaceuticals PLC v. Novartis Pharmaceuticals Corporation
Breckenridge Pharmaceutial, Inc. v. Novartis Pharmaceuticals Corporation
Breckenridge Pharmaceutical, Inc. v. Novartis AG
Roxane Laboratories, Inc. et al. v. Novartis AG
Par Pharmaceutical, Inc. et al. v. Novartis AG
BRECKENRIDGE PHARMACEUTICAL, INC. v. Novartis AG
Par Pharmaceutical, Inc. et al. v. Novartis AG
Par Pharmaceutical, Inc. et al. v. Novartis AG
Par Pharmaceutical, Inc. et al. v. Novartis AG
Patents Involved
There are 7 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5665772
O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
|
Filed: 1993-09-24
Issued: 1997-09-09
|
Expired (Term Ended)
+2176d PTA
Expires: 2019-09-09
|
|
|
US8410131
Cancer treatment
|
Filed: 2002-02-18
Issued: 2013-04-02
|
Expired (Term Ended)
+1352d PTA
Expires: 2025-11-01
|
|
|
US8778962
Treatment of solid tumors with rapamycin derivatives
|
Filed: 2012-07-11
Issued: 2014-07-15
|
Active (5.6 yrs remaining)
Expires: 2032-07-11
|
|
|
US7297703
Macrolides
|
Filed: 2004-12-23
Issued: 2007-11-20
|
Expired (Term Ended)
Expires: 2024-12-23
|
|
|
US7741338
Macrolides
|
Filed: 2009-07-06
Issued: 2010-06-22
|
Active (2.6 yrs remaining)
Expires: 2029-07-06
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
High PTA (+2176 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
43
Dispositive
0
Granted
2
Denied
0
Pending / Review
28
Motions by Category
Key Dispositive Motions & Rulings